JPMorgan Chase & Co. lifted its position in Anterix Inc. (NASDAQ:ATEX - Free Report) by 188.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 33,832 shares of the company's stock after acquiring an additional 22,092 shares during the period. JPMorgan Chase & Co. owned 0.18% of Anterix worth $1,274,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in ATEX. FMR LLC lifted its holdings in shares of Anterix by 76.4% during the third quarter. FMR LLC now owns 250,955 shares of the company's stock valued at $9,451,000 after purchasing an additional 108,683 shares during the last quarter. Jane Street Group LLC raised its stake in Anterix by 78.2% during the third quarter. Jane Street Group LLC now owns 128,892 shares of the company's stock valued at $4,854,000 after buying an additional 56,559 shares during the last quarter. Marshall Wace LLP boosted its holdings in Anterix by 250.2% in the second quarter. Marshall Wace LLP now owns 58,652 shares of the company's stock worth $2,322,000 after acquiring an additional 41,905 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Anterix in the second quarter worth $1,334,000. Finally, Paloma Partners Management Co bought a new position in shares of Anterix during the third quarter valued at $769,000. Hedge funds and other institutional investors own 87.67% of the company's stock.
Wall Street Analyst Weigh In
Separately, Craig Hallum upgraded shares of Anterix to a "strong-buy" rating in a research note on Wednesday, October 9th.
Check Out Our Latest Stock Analysis on Anterix
Insiders Place Their Bets
In related news, Director Mark Fleischhauer purchased 3,500 shares of Anterix stock in a transaction dated Thursday, December 5th. The stock was purchased at an average cost of $34.19 per share, for a total transaction of $119,665.00. Following the completion of the purchase, the director now directly owns 3,500 shares of the company's stock, valued at $119,665. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Leslie B. Daniels acquired 2,000 shares of the firm's stock in a transaction dated Wednesday, November 20th. The shares were bought at an average cost of $32.75 per share, with a total value of $65,500.00. Following the completion of the acquisition, the director now directly owns 2,000 shares of the company's stock, valued at $65,500. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 45.61% of the company's stock.
Anterix Price Performance
NASDAQ ATEX traded up $0.29 during mid-day trading on Friday, reaching $29.81. The stock had a trading volume of 84,246 shares, compared to its average volume of 119,127. The stock has a market cap of $555.06 million, a PE ratio of -14.76 and a beta of 0.87. Anterix Inc. has a 1 year low of $27.37 and a 1 year high of $42.41. The company has a fifty day moving average price of $31.63 and a 200 day moving average price of $34.94.
About Anterix
(
Free Report)
Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.
Further Reading

Before you consider Anterix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anterix wasn't on the list.
While Anterix currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.